Priority Date: 03.10.11 (EP 20110183678)

NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF

  • Application ID: EP12766991
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

Company dna icosa
no operation time available
635.78
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Icosa is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.10.2011 - Priority Date (EP 20110183678)
  • 11.04.2013 - Publication A1 (WO2013050424)
  • 13.08.2014 - Publication A1 (EP2763992)
  • 06.04.2016 - Publication B1 (EP2763992)
  • 24.08.2016 - Publication B9 (EP2763992)

IPC Classification